Literature DB >> 1500534

Primary isolation of human T-cell leukemia-lymphoma virus types I and II: use for confirming infection in seroindeterminate blood donors.

B Hjelle1, R Mills, C Goldsmith, S G Swenson, S Cyrus.   

Abstract

We describe the use of an immunofluorescence assay and coculture to confirm human T-cell leukemia-lymphoma virus (HTLV) infection. Peripheral blood mononuclear cells from 32 of 32 seropositive donors were positive in the immunofluorescence assay, and 63% of their cocultures produced p24 antigen. Specific antibodies distinguished HTLV type I (HTLV-I) from HTLV-II. HTLV-I or HTLV-II was isolated from donors with indeterminate serologic test results.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1500534      PMCID： PMC265471          DOI： 10.1128/jcm.30.8.2195-2199.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  PLASTIC EMBEDDING MIXTURES FOR USE IN ELECTRON MICROSCOPY.

Authors:  H H MOLLENHAUER
Journal:  Stain Technol       Date:  1964-03

2.  Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals.

Authors:  J J Lipka; K K Young; S Y Kwok; G R Reyes; J J Sninsky; S K Foung
Journal:  Vox Sang       Date:  1991       Impact factor: 2.144

3.  Low incidence of HTLV infections in random blood donors with indeterminate western blot patterns.

Authors:  S Kwok; J J Lipka; N McKinney; D E Kellogg; B Poiesz; S K Foung; J J Sninsky
Journal:  Transfusion       Date:  1990 Jul-Aug       Impact factor: 3.157

4.  Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide.

Authors:  E P Lillehoj; S S Alexander; C J Dubrule; S Wiktor; R Adams; C C Tai; A Manns; W A Blattner
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  Serologic distinction between human T-lymphotropic virus (HTLV) type I and HTLV type II.

Authors:  B Hjelle; S Cyrus; S Swenson; R Mills
Journal:  Transfusion       Date:  1991-10       Impact factor: 3.157

6.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Authors:  V S Kalyanaraman; M G Sarngadharan; M Robert-Guroff; I Miyoshi; D Golde; R C Gallo
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

7.  Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?

Authors:  R F Khabbaz; D Hartel; M Lairmore; C R Horsburgh; E E Schoenbaum; B Roberts; T M Hartley; G Friedland
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

8.  Chronic neurodegenerative disease associated with HTLV-II infection.

Authors:  B Hjelle; O Appenzeller; R Mills; S Alexander; N Torrez-Martinez; R Jahnke; G Ross
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

9.  Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population.

Authors:  B Hjelle; R Mills; S Swenson; G Mertz; C Key; S Allen
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

10.  Detection of HTLV-I genome in seronegative infants born to HTLV-I seropositive mothers by polymerase chain reaction.

Authors:  S Saito; Y Ando; K Furuki; K Kakimoto; T Tanigawa; I Moriyama; M Ichijo; M Nakamura; K Ohtani; K Sugamura
Journal:  Jpn J Cancer Res       Date:  1989-09
View more
  2 in total

1.  Isolation, characterization, and transmission of human T-lymphotropic virus types I and II in culture.

Authors:  K Kitamura; D L Rudolph; C Goldsmith; T M Folks; R B Lal
Journal:  Curr Microbiol       Date:  1993-12       Impact factor: 2.188

2.  No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran.

Authors:  Houshang Rafatpanah; Farhad Fathimoghadam; Majid Shahabi; Iman Eftekharzadeh; Mohammadreza Hedayati-Moghaddam; Narges Valizadeh; Mohsen Tadayon; Seyyed Aliakbar Shamsian; Hamidreza Bidkhori; Raheleh Miri; Ali Bazarbachi
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.